The therapeutic potential of monoclonal antibodies against respiratory syncytial virus (Q45439981)

14 December 2017

title

The therapeutic potential of monoclonal antibodies against respiratory syncytial virus (English)

1 reference

14 December 2017

Weltzin R

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

Expert Opinion on Investigational Drugs

14 December 2017

published in

1 reference

14 December 2017

1 reference

14 December 2017

1 reference

14 December 2017

page(s)

1271-1283

1 reference

Purification and characterization of the respiratory syncytial virus fusion protein

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Modes of transmission of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Economic impact of viral respiratory disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Respiratory syncytial virus infection in immunocompromised adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Respiratory Syncytial Virus Infections within Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Immunity to and frequency of reinfection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Distinct types of lung disease caused by functional subsets of antiviral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Immunoprophylaxis and the control of respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Monoclonal antibodies to respiratory syncytial virus: Detection of virus neutralization and other antigen-antibody systems using infected human and murine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

The development of monoclonal antibodies to respiratory syncytial virus and their use in diagnosis by indirect immunofluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Comparative studies on human and rabbit exocrine IgA antibodies to an albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

The nasal mucociliary clearance: relevance to nasal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Cloning, expression and functional activities of a single chain antibody fragment directed to fusion protein of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Combination antiviral therapy for respiratory virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1271

10.1517/13543784.7.8.1271

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference